Drug-Releasing ear implant could boost hearing for millions

NCT ID NCT06598059

Ongoing Symptom relief Sponsor: Cochlear Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new cochlear implant that slowly releases a drug called dexamethasone to reduce swelling and tissue damage after surgery. The goal is to see if this helps the implant work better and improve hearing in adults with severe hearing loss. About 56 adults will receive the implant and be monitored for up to 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fibrosis hearing loss disorder sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEARING LOSS

Contacts and locations

Locations

Henry Ford Health

Detroit, Michigan, 48202, United States
Medical University of South Carolina

Charleston, South Carolina, 29425, United States
NYU Langone Health

New York, New York, 10017, United States
New York Eye and Ear Infirmary

New York, New York, 10010, United States
Northwell Health Long Island Jewish Medical Center

New York, New York, 11042, United States
Oregon Health & Science University

Portland, Oregon, 97239, United States
Rocky Mountain Ear Center

Englewood, Colorado, 80113, United States
UCLA Medical Center

Los Angeles, California, 90095, United States
University Hospitals

Cleveland, Ohio, 44106, United States
University of Iowa

Iowa City, Iowa, 52242, United States
Washington University

St Louis, Missouri, 63141, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.